Search Within

Samuel Singer

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (11)
Groups
  1. Body Imaging Service (24)
  2. Department of Medicine (24)
  3. GSK Faculty (24)
  4. Molecular Imaging and Therapy Service (24)
  5. Radiology, Department of (24)
  6. Sarcoma Service (24)

More Groups

People
  1. William Tap (24)
  2. Mark Dickson (23)
  3. Li-Xuan Qin (21)
  4. Mary Keohan (21)
  5. Mrinal Gounder (21)
  6. Sandra D'Angelo (21)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (2)
  4. The Oncologist (2)
  5. Annals of Oncology (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (3)
  4. American Medical Association (2)
  5. Elsevier Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: A genomic and clinicopathologic study
    Journal Article

    Dermawan, J. K.; Hwang, S.; Wexler, L.; Tap, W. D.; Singer, S.; Vanderbilt, C. M.; Antonescu, C. R.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term follow-up and patterns of response, progression, and hyperprogression in patients after PD-1 blockade in advanced sarcoma
    Journal Article

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save